Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 82 | 1 | 32 | 1 | €870.00 | €900.00 | 3.448% |
| Biogen Inc. | 73 | 1 | 23 | 0 | €211.00 | €282.11 | 33.703% |
| Boston Scientific | 71 | 0 | 23 | 0 | €71.50 | €79.29 | 10.892% |
| Vertex Pharmaceuticals Inc. | 71 | 2 | 24 | 0 | €448.15 | €515.91 | 15.120% |
| Regeneron Pharmaceuticals Inc. | 62 | 1 | 24 | 0 | €1,009.0 | €1,072.3 | 6.270% |
| Johnson & Johnson | 57 | 2 | 24 | 1 | €137.48 | €163.24 | 18.737% |
| Neurocrine Bioscience | 54 | 0 | 22 | 0 | €135.15 | €150.00 | 10.988% |
| Intuitive Surgical Inc | 54 | 0 | 21 | 0 | €407.30 | €450.00 | 10.484% |
| UnitedHealth Group Inc. | 55 | 2 | 20 | 1 | €469.10 | €527.50 | 12.449% |
| Intra-Cellular Therapies Inc. | 49 | 0 | 23 | 0 | €72.00 | €85.00 | 18.056% |
| AbbVie Inc. | 48 | 0 | 26 | 0 | €156.18 | €176.57 | 13.054% |
| Merck & Co. Inc. | 49 | 1 | 20 | 0 | €117.20 | €125.66 | 7.217% |
| Thermo Fisher Scientific Inc. | 48 | 0 | 21 | 0 | €502.80 | €560.00 | 11.376% |
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | €239.00 | €256.18 | 7.189% |
| Pfizer Inc. | 50 | 4 | 23 | 0 | €26.52 | €33.45 | 26.146% |
| Amgen Inc. | 45 | 0 | 22 | 0 | €303.35 | €320.00 | 5.489% |
| Insmed Inc. | 42 | 1 | 12 | 1 | €70.50 | €76.71 | 8.807% |
| Stryker Corp. | 42 | 1 | 18 | 1 | €311.30 | €340.00 | 9.219% |
| Abbott Laboratories | 38 | 0 | 20 | 0 | €95.59 | €109.09 | 14.128% |
| Illumina Inc. | 44 | 6 | 24 | 2 | €106.42 | €140.00 | 31.554% |
| EyePoint Pharmaceuticals Inc. | 37 | 1 | 18 | 0 | €9.48 | €23.89 | 152.068% |
| Tenet Healthcare | 35 | 0 | 3 | 0 | €124.00 | €129.16 | 4.165% |
| Dexcom Inc. | 34 | 0 | 17 | 0 | €104.60 | €120.81 | 15.499% |
| Zoetis Inc. A | 35 | 1 | 12 | 0 | €164.20 | €181.79 | 10.713% |
| Cytokinetics Inc. | 34 | 1 | 2 | 0 | €51.00 | €83.56 | 63.844% |